Investigator Meetings

April 2024
March 2024
March 2023
April 6, 2024 Investigator Meeting - General Session - Milan, Italy

Please note:

Dr. Rohit Aggarwal's presentation, "Reducing Placebo Response and Assessment Variability" did not take place at the Milan Investigator Meeting as scheduled

The presentation was previously given at the March 2024 Miami meeting and is available in the tab to the left (scroll down to Day 2 - Session 2)

Video 1

Opening Presentation (Benjamin Zimmer)

Video 2

Mastering the CDASI Across Skin Types (Katharina Shaw, MD)

Video 3

Enrollment Workshop (Dr. Zoltán Griger, Dr. Yu-Jih Ben Su, Dr. Krasimir Kraev, Scott Jones)

Video 4

Rescue Therapy and Clinical Worsening Best Practices

Video 5

Closing Presentation (Benjamin Zimmer)

March 2024 Investigator Meeting - Miami, Florida

Selected Highlights Video

Day 1 - Argentina, Colombia, Mexico, Chile Sessions
Link to slides for all Day 1 sessions:

Session 1

Opening Remarks (Benjamin Zimmer)

Communication and Partnership with Priovant (Benjamin Zimmer)

Pre-Screening Best Practices (Courtney Cupples)

Screening Logistics Best Practices (Courtney Cupples)

Sessions 2 and 3

Lessons from Top Enrollers (Dr. Gabriel Medrano Ramirez, Dr. Francisca Bozan)

Session 4

Screening Best Practices for Study Coordinators (Drew Webster)

Day 2 - Main Sessions

Session 1

Update on VALOR Study and Brepocitinib Development (Benjamin Zimmer)

Link to slides:

Session 2

Reducing Placebo Response and Assessment Variability (Dr. Rohit Aggarwal)

Link to slides:

Session 3

CDASI in Varied Skin Tones (Dr. Ruth Ann Vleugels)

Session 4

Lessons from High Enrolling Sites (Dr. Aaron Mangold, Dr. Prateek Gandiga, Scott Jones)

Link to slides:

Session 5

Protocol Case Studies (Ade Adeboye)

Link to slides:

Session 6

Study Coordinator Breakout Session (Scott Jones)

Link to slides:

Closing Session

Closing Remarks (Benjamin Zimmer)

Link to slides:
Site Training Materials

VALOR Study Rater Training - EU Investigator Meeting

To watch the video, please enter the same password you used to get to this page.
© 2024 All rights reserved. Priovant Therapeutics, Inc.